로딩 중…
StockDiggingStockDigging

일신바이오

068330· KOSDAQ
₩1,074-4.62%
2026-06-19

Price Chart

일신바이오-42.78%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap47.49B KRW
Revenue15.16B KRW
Net Income5.11B KRW
Total Assets72.69B KRW
Net Assets65.35B KRW
Employees37
Value
P/E9.30x
P/B0.73x
PEG0.20x
P/S3.13x
EV/EBITDA10.06x
FCF Yield11.08%
Profitability
ROE7.81%
ROA7.02%
Op. Margin30.06%
Revenue Growth33.54%
Earnings Growth47.20%
Financial Health
Debt Ratio111.22%
Total Debt0 KRW
FCF5.26B KRW
Cash1.66B KRW
Current Ratio8.32x
Net Debt/EBITDA-0.36x
Dividend
Div. Yield0.89%
Div. Growth42.86%
Performance
1Y Return-42.78%
1M Return-13.94%
From 52W High-53.91%
1Y MDD-52.53%
Trading
Volume106,824 shares
Foreign Own.3.15%
Per Share
EPS115 KRW
BPS1,568 KRW

Company Info

CEO 홍성대
Employees 37
Founded 1994
HQ 경기도 동두천시, KR

Established in 1988 and converted to a corporation in 1994, the company was listed on KOSDAQ in 2007 and changed its name to Ilshinbiobase in 2009. It specializes in bio-equipment, manufacturing, selling, and exporting research equipment like lyophilizers for biotechnology research and ultra-low temperature freezers, alongside large industrial lyophilizers. Leveraging vacuum, refrigeration, and control technologies, the company offers a diverse product lineup and pursues growth by developing high-performance automatic control systems and expanding global GMP-compliant models. Ilshinbio is headquartered in Dongducheon-si, Gyeonggi-do.